24 May 2013
Keywords: schering, ag, continues, its, strategic, review, german
Article | 12 December 2005
German pharmaceutical firm Schering AG says it is reviewing its strategic alternatives for its CIS bio International radiopharmaceutical business. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.